Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.
暂无分享,去创建一个
D. Hill | R. McLeod | P. Meier | T. Karrison | K. Wroblewski | P. Heydemann | K. Boyer | E. Mui | A. Noble | C. Swisher | S. Withers | J. Dubey | Daniel Lee | J. Babiarz | Mari Sautter | Tiffany Hosten
[1] D. Hill,et al. Identification of a Sporozoite-Specific Antigen from Toxoplasma gondii , 2011, The Journal of parasitology.
[2] R. McLeod,et al. Clinical Manifestations of Ocular Toxoplasmosis , 2011, Ocular immunology and inflammation.
[3] A. Montpetit,et al. NALP1 Influences Susceptibility to Human Congenital Toxoplasmosis, Proinflammatory Cytokine Response, and Fate of Toxoplasma gondii-Infected Monocytic Cells , 2010, Infection and Immunity.
[4] J. Blackwell,et al. P2X7 Receptor-Mediated Killing of an Intracellular Parasite, Toxoplasma gondii, by Human and Murine Macrophages , 2010, The Journal of Immunology.
[5] J. Blackwell,et al. Host genetic and epigenetic factors in toxoplasmosis. , 2009, Memorias do Instituto Oswaldo Cruz.
[6] R. McLeod,et al. Why prevent, diagnose and treat congenital toxoplasmosis? , 2009, Memorias do Instituto Oswaldo Cruz.
[7] Annie F Kuo,et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. , 2008, American journal of ophthalmology.
[8] R. McLeod,et al. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. , 2008, Archives of ophthalmology.
[9] Martine Wallon,et al. Genetic and Epigenetic Factors at COL2A1 and ABCA4 Influence Clinical Outcome in Congenital Toxoplasmosis , 2008, PloS one.
[10] Annie F Kuo,et al. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. , 2008, Ophthalmology.
[11] R. McLeod,et al. Cataracts in congenital toxoplasmosis. , 2007, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[12] R. McLeod,et al. Impact of Visual Impairment on Measures of Cognitive Function for Children With Congenital Toxoplasmosis: Implications for Compensatory Intervention Strategies , 2006, Pediatrics.
[13] R. McLeod,et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] D. Hill,et al. Biology and epidemiology of Toxoplasma gondii in man and animals , 2005, Animal Health Research Reviews.
[15] J. Levy,et al. Humane strategies for controlling feral cat populations. , 2004, Journal of the American Veterinary Medical Association.
[16] J. Shenai,et al. Infectious Diseases of the Fetus and Newborn Infant , 2001, Journal of Perinatology.
[17] F. Roberts,et al. HLA-class II genes modify outcome of Toxoplasma gondii infection. , 1999, International journal for parasitology.
[18] J. Isaac-Renton,et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. , 1998, Ophthalmology.
[19] R. McLeod,et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. , 1996, Radiology.
[20] N. Roizen,et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] R. McLeod,et al. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group , 1992, Antimicrobial Agents and Chemotherapy.
[22] R. McLeod,et al. Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis , 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[23] S. Teutsch,et al. Epidemic toxoplasmosis associated with infected cats. , 1979, The New England journal of medicine.
[24] J. K. Frenkel,et al. Ocular toxoplasmosis; pathogenesis, diagnosis and treatment. , 1958, A.M.A. archives of ophthalmology.
[25] F. Wilcoxon. Individual Comparisons by Ranking Methods , 1945 .
[26] E. Levine. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. , 2006, American journal of obstetrics and gynecology.
[27] R. McLeod,et al. Eye manifestations of congenital toxoplasmosis. , 1996, American journal of ophthalmology.
[28] R. McLeod,et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. , 1995, Pediatrics.
[29] R. Dailly. [ACQUIRED TOXOPLASMOSIS]. , 1964, La Presse medicale.
[30] J. Couvreur,et al. [Acquired toxoplasmosis. (Study of 227 cases)]. , 1960, Archives francaises de pediatrie.